DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products ...
Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 13. Analyst Mike Kratky from ...
Hosted on MSN5mon
Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's likeDexcom launched its first over-the-counter continuous ... which is updated every 15 minutes. They'll also see a graph of their readings each day, which includes a shaded green area to indicate ...
Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year ...
The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...
To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dexcom CEO Kevin Sayer shared new data on the company’s first over-the-counter glucose sensor at the J.P ...
You can see how EPS has changed over time in the image below (click on the chart to see the exact values). NasdaqGS:DXCM Earnings Per Share Growth January 18th 2025 We know that DexCom has improved ...
Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors for people with diabetes—just weeks after a ...
Furthermore, you'd generally like to see... Investing.com -- Baird upgraded DexCom Inc (NASDAQ:DXCM). to "Outperform" from "Neutral," citing progress in U.S. sales and upcoming catalysts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback